Clinical Trial Update: Ebola and Marburg Virus Vaccines [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Ebola and Marburg virus vaccines has completed. The study was sponsored by the National Institute of Allergy and Infectious Diseases …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease
• Marburg Virus Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Vaccines, Marburg Virus Disease | Phase 1 | Status: COMPLETED